Professor Mibel Aguilar is a Bioanalytical and Biophysical Chemist at Monash University whose research focuses on biomembrane nanotechnology, peptidomimetic drug design and biomaterials for regenerative medicine. She completed her PhD in Chemistry at the University of Melbourne studying the metabolism and toxicity of paracetamol. She then completed a Post Doctoral position at St Vincent’s Institute for Medical Research working on developing physical models for protein analysis and purification. She then moved to Monash University where her group now focuses on peptide-based biomaterials and drug design and biomembrane nanotechnology and are developing novel compounds that allow us to exploit the potential of peptides as drugs. She has published 200 papers and 26 book chapters, and edited a volume of Methods in Molecular Biology on HPLC publications. She has also supervised several PhD and Honours students. Her group focuses on peptide-based drug and biomaterial design and biomembrane nanotechnology. They are developing novel compounds that allow us to exploit the potential of peptides as drugs, with a focus on new compounds for treatments of cardiovascular disease. They are also developing novel self-assembling systems for the production of new biomaterials and nanomaterials for tissue engineering. Their membrane nanotechnology projects involve the development of new biosensor methods for the analysis of membrane-mediated processes such as apoptosis, G protein-coupled receptor function and antimicrobial peptide function.